Please assess the completion status of the following clinical trial:

Trial Title: Hyperbaric Bupivacaine Versus Hyperbaric Prilocaine 2% for Cesarean Section Under Spinal Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria :~* American Society of Anesthesiologists physical status (ASA) \< III~* Age 18-40 year~* Body Weight \<110 kg~* Height between 160 and 175 cm~* Gestational age\>37 SA~* Elective cesarean delivery~* Singleton pregnancy~* Non complicated pregnancy~* Signed informed consent obtained prior to any study specific assessments and procedures~Exclusion Criteria:~* Twin pregnancy~* History of 2 cesarean section or more~* Diabetes and gestational diabetes~* Placenta praevia~* Congenital foetal abnormality~* Intrauterine growth retardation~* Patient in labour~* Membrane rupture~* Known allergy to local anaesthetics~* Standard contraindications to neuraxial block.~* Disagreement of the patient~* Neurological impairment~* Gestational low blood pressure~* Pre eclampsia and eclampsia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Hyperbaric bupivacaine (Type: PLACEBO_COMPARATOR): Hyperbaric bupivacaine 0.5% will be administered at the dose of 10 mg intrathecally associated with 100 µg of morphine and 2.5 µg of sufentanyl.
- Hyperbaric prilocaine (Type: ACTIVE_COMPARATOR): Hyperbaric prilocaine 2% will be administered at the dose of 50 mg intrathecally associated with 100 µg of morphine and 2.5 µg of sufentanyl.

Based on this trial design, predict the completion outcome and termination type (if applicable).